210 related articles for article (PubMed ID: 30404132)
1. Apoprotein E and Reverse Cholesterol Transport.
Getz GS; Reardon CA
Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30404132
[TBL] [Abstract][Full Text] [Related]
2. Macrophage, but not systemic, apolipoprotein E is necessary for macrophage reverse cholesterol transport in vivo.
Zanotti I; Pedrelli M; Potì F; Stomeo G; Gomaraschi M; Calabresi L; Bernini F
Arterioscler Thromb Vasc Biol; 2011 Jan; 31(1):74-80. PubMed ID: 20966401
[TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein E regulation of myeloid cell plasticity in atherosclerosis.
Raffai RL
Curr Opin Lipidol; 2012 Oct; 23(5):471-8. PubMed ID: 22892903
[TBL] [Abstract][Full Text] [Related]
4. Triacylglycerol-rich lipoproteins alter the secretion, and the cholesterol-effluxing function, of apolipoprotein E-containing lipoprotein particles from human (THP-1) macrophages.
Lindholm EM; Palmer AM; Graham A
Biochem J; 2001 Jun; 356(Pt 2):515-23. PubMed ID: 11368780
[TBL] [Abstract][Full Text] [Related]
5. EP 80317, a CD36 selective ligand, promotes reverse cholesterol transport in apolipoprotein E-deficient mice.
Bujold K; Mellal K; Zoccal KF; Rhainds D; Brissette L; Febbraio M; Marleau S; Ong H
Atherosclerosis; 2013 Aug; 229(2):408-14. PubMed ID: 23880196
[TBL] [Abstract][Full Text] [Related]
6. Novel Apo E-Derived ABCA1 Agonist Peptide (CS-6253) Promotes Reverse Cholesterol Transport and Induces Formation of preβ-1 HDL In Vitro.
Hafiane A; Bielicki JK; Johansson JO; Genest J
PLoS One; 2015; 10(7):e0131997. PubMed ID: 26207756
[TBL] [Abstract][Full Text] [Related]
7. Atherosclerosis and apoprotein E. An enigmatic relationship.
Getz GS; Mazzone T; Soltys P; Bates SR
Arch Pathol Lab Med; 1988 Oct; 112(10):1048-55. PubMed ID: 3052355
[TBL] [Abstract][Full Text] [Related]
8. Sage weed (Salvia plebeia) extract antagonizes foam cell formation and promotes cholesterol efflux in murine macrophages.
Park SH; Kim JL; Kang MK; Gong JH; Han SY; Shim JH; Lim SS; Kang YH
Int J Mol Med; 2012 Nov; 30(5):1105-12. PubMed ID: 22922992
[TBL] [Abstract][Full Text] [Related]
9. Modulation of THP-1 macrophage and cholesterol-loaded foam cell apolipoprotein E levels by glycosphingolipids.
Garner B; Mellor HR; Butters TD; Dwek RA; Platt FM
Biochem Biophys Res Commun; 2002 Feb; 290(5):1361-7. PubMed ID: 11820771
[TBL] [Abstract][Full Text] [Related]
10. Independent protective roles for macrophage Abcg1 and Apoe in the atherosclerotic lesion development.
Lammers B; Out R; Hildebrand RB; Quinn CM; Williamson D; Hoekstra M; Meurs I; Van Berkel TJ; Jessup W; Van Eck M
Atherosclerosis; 2009 Aug; 205(2):420-6. PubMed ID: 19217108
[TBL] [Abstract][Full Text] [Related]
11. Medium-chain triglycerides promote macrophage reverse cholesterol transport and improve atherosclerosis in ApoE-deficient mice fed a high-fat diet.
Zhang X; Zhang Y; Liu Y; Wang J; Xu Q; Yu X; Yang X; Liu Z; Xue C
Nutr Res; 2016 Sep; 36(9):964-973. PubMed ID: 27632916
[TBL] [Abstract][Full Text] [Related]
12. Transient Receptor Potential Ankyrin 1 Channel Involved in Atherosclerosis and Macrophage-Foam Cell Formation.
Zhao JF; Shyue SK; Kou YR; Lu TM; Lee TS
Int J Biol Sci; 2016; 12(7):812-23. PubMed ID: 27313495
[TBL] [Abstract][Full Text] [Related]
13. Retinoic acid induces macrophage cholesterol efflux and inhibits atherosclerotic plaque formation in apoE-deficient mice.
Zhou W; Lin J; Chen H; Wang J; Liu Y; Xia M
Br J Nutr; 2015 Aug; 114(4):509-18. PubMed ID: 26201974
[TBL] [Abstract][Full Text] [Related]
14. Macrophage Mitochondrial Energy Status Regulates Cholesterol Efflux and Is Enhanced by Anti-miR33 in Atherosclerosis.
Karunakaran D; Thrush AB; Nguyen MA; Richards L; Geoffrion M; Singaravelu R; Ramphos E; Shangari P; Ouimet M; Pezacki JP; Moore KJ; Perisic L; Maegdefessel L; Hedin U; Harper ME; Rayner KJ
Circ Res; 2015 Jul; 117(3):266-78. PubMed ID: 26002865
[TBL] [Abstract][Full Text] [Related]
15. Increased atherosclerosis in P2Y13/apolipoprotein E double-knockout mice: contribution of P2Y13 to reverse cholesterol transport.
Lichtenstein L; Serhan N; Espinosa-Delgado S; Fabre A; Annema W; Tietge UJ; Robaye B; Boeynaems JM; Laffargue M; Perret B; Martinez LO
Cardiovasc Res; 2015 May; 106(2):314-23. PubMed ID: 25770145
[TBL] [Abstract][Full Text] [Related]
16. Alginic acid cell entrapment: a novel method for measuring in vivo macrophage cholesterol homeostasis.
Sontag TJ; Chellan B; Bhanvadia CV; Getz GS; Reardon CA
J Lipid Res; 2015 Feb; 56(2):470-83. PubMed ID: 25465389
[TBL] [Abstract][Full Text] [Related]
17. Excess nitric oxide impairs LXR(α)-ABCA1-dependent cholesterol efflux in macrophage foam cells.
Zhao JF; Shyue SK; Lin SJ; Wei J; Lee TS
J Cell Physiol; 2014 Jan; 229(1):117-25. PubMed ID: 23836449
[TBL] [Abstract][Full Text] [Related]
18. The future of apolipoprotein E mimetic peptides in the prevention of cardiovascular disease.
Valanti EK; Chroni A; Sanoudou D
Curr Opin Lipidol; 2019 Aug; 30(4):326-341. PubMed ID: 31157629
[TBL] [Abstract][Full Text] [Related]
19. Cholesteryl ester transfer protein decreases high-density lipoprotein and severely aggravates atherosclerosis in APOE*3-Leiden mice.
Westerterp M; van der Hoogt CC; de Haan W; Offerman EH; Dallinga-Thie GM; Jukema JW; Havekes LM; Rensen PC
Arterioscler Thromb Vasc Biol; 2006 Nov; 26(11):2552-9. PubMed ID: 16946130
[TBL] [Abstract][Full Text] [Related]
20. Lysophosphatidylcholine promotes cholesterol efflux from mouse macrophage foam cells via PPARgamma-LXRalpha-ABCA1-dependent pathway associated with apoE.
Hou M; Xia M; Zhu H; Wang Q; Li Y; Xiao Y; Zhao T; Tang Z; Ma J; Ling W
Cell Biochem Funct; 2007; 25(1):33-44. PubMed ID: 16981222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
